KIT and PDGF as targets

Cancer Treat Res. 2004;120:117-27. doi: 10.1007/1-4020-7856-0_7.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Gastrointestinal Neoplasms / drug therapy
  • Gastrointestinal Neoplasms / metabolism
  • Humans
  • Imatinib Mesylate
  • Piperazines / therapeutic use*
  • Platelet-Derived Growth Factor / metabolism*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Proto-Oncogene Proteins c-kit / metabolism*
  • Pyrimidines / therapeutic use*
  • Receptors, Platelet-Derived Growth Factor / metabolism
  • Sarcoma / drug therapy*
  • Sarcoma / metabolism
  • Soft Tissue Neoplasms / drug therapy*
  • Soft Tissue Neoplasms / metabolism

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Platelet-Derived Growth Factor
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins c-kit
  • Receptors, Platelet-Derived Growth Factor